RP Bio Inc. (KOSDAQ:314140)
6,140.00
-10.00 (-0.16%)
At close: May 8, 2026
11.23% (1Y)
| Market Cap | 50.96B +12.2% |
| Revenue (ttm) | 136.22B +9.9% |
| Net Income | 4.68B |
| EPS | 541.00 |
| Shares Out | 8.67M |
| PE Ratio | 10.87 |
| Forward PE | n/a |
| Dividend | 50.00 (0.81%) |
| Ex-Dividend Date | Dec 29, 2025 |
| Volume | 11,770 |
| Average Volume | 14,463 |
| Open | 6,150.00 |
| Previous Close | 6,150.00 |
| Day's Range | 6,000.00 - 6,190.00 |
| 52-Week Range | 5,480.00 - 9,130.00 |
| Beta | 0.52 |
| RSI | 43.10 |
| Earnings Date | n/a |